Related Experiment Video
Updated: Apr 15, 2026

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD
Published on: September 13, 2018
Long-term outcomes of children with intermediate sweat chloride values in infancy
Tyler Groves1, Paul Robinson2, Veronica Wiley3
1Sydney Medical School, University of Sydney, New South Wales, Australia; Department of Respiratory Medicine, The Children's Hospital at Westmead, New South Wales, Australia.
Insights
Approximately half of infants with intermediate sweat chloride values are diagnosed with cystic fibrosis (CF) later. This delayed CF diagnosis often presents with milder disease compared to newborn screening positive CF, highlighting the need for continued infant monitoring.
Area of Science:
- Pediatrics
- Genetics
- Pulmonology
Background:
- Intermediate sweat chloride values in newborns require careful follow-up for cystic fibrosis (CF).
- Newborn screening (NBS) protocols identify infants at risk for CF, but some cases are diagnosed later.
Purpose of the Study:
- To describe the clinical course of children with intermediate sweat chloride values.
- To compare the outcomes of children with delayed CF diagnosis versus those identified through NBS.
Main Methods:
- Retrospective review of children with intermediate sweat chloride values (30-59 mmol/L) over 15 years.
- Matching patients with delayed CF diagnosis to NBS-positive CF patients (2:1 ratio).
- Comparison of clinical outcomes including pancreatic insufficiency, bacterial colonization, lung function, and disease severity.
Main Results:
- 48% of infants with intermediate sweat chloride values were later diagnosed with CF.
- Delayed CF diagnosis was associated with significantly less pancreatic insufficiency and nonmucoid Pseudomonas aeruginosa colonization.
- Milder obstructive lung disease and overall disease severity (Shwachman scores) were observed in delayed CF cases at 10 years.
Conclusions:
- About half of infants with intermediate sweat chloride values develop CF.
- Children with delayed CF diagnosis exhibit a milder clinical course in several aspects compared to NBS-positive CF.
- Ongoing follow-up is crucial for infants identified with intermediate sweat chloride values.
Objective:
To describe the clinical course of children who have intermediate sweat chloride values on initial screening for cystic fibrosis (CF).
Study Design:
We performed a retrospective review of children with intermediate sweat chloride values (raised immunoreactive trypsinogen/1 copy of p.F508del CF mutation on newborn screening (NBS)/sweat chloride value of 30-59 mmol/L) presenting to The Children's Hospital at Westmead over 15 years. Patients with an intermediate sweat chloride evolving to a formal diagnosis of CF (termed "delayed CF") were matched (2:1) with NBS positive patients with CF (termed "NBS positive CF"). Clinical outcomes were compared.
Results:
Fourteen of 29 (48%, 95% CI 0.3-0.66) patients with intermediate sweat chloride value evolved to a diagnosis of CF and were matched with 28 NBS positive patients with CF. Delayed CF had less pancreatic insufficiency (OR 0.06, 95% CI 0.01-0.44, P = .006), less colonization with nonmucoid Pseudomonas aeruginosa (OR 0.04, 95% CI 0.01-0.38, P = .005), milder obstructive lung disease (forced expiratory volume in 1 second/forced vital capacity ratio), and overall disease severity (Shwachman scores) at 10 years (mean difference 5.93, 95% CI 0.39-11.46, P = .04; mean difference 4.72, 95% CI 0.9-8.53, P = .015, respectively). Nutritional outcomes were better at 2 years for delayed CF but did not persist to later ages.
Conclusions:
In this cohort, approximately one-half of infants with intermediate sweat chloride value were later diagnosed with CF. The clinical course of delayed CF was milder in some aspects compared with NBS positive CF. These results emphasize the importance of ongoing follow-up of infants with intermediate sweat chloride values.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Development of Human Microbiota
Cystic Fibrosis: Management
Sinus disease and chronic...
Socioemotional Development during Infancy
Primary Temperament Types

